CST4 and cancer: In many cancers, cystatin levels are often decreased, leading to unregulated protease activity and facilitating cancer progression.20,21 Conversely, higher cystatin expression may impede metastasis by reducing protease activity, though some aggressive cancers may develop mechanisms to bypass this inhibition.22-24